In a landmark achievement for regional medical research, CariGenetics has successfully exceeded its recruitment objectives for the Caribbean Prostate Cancer Genomics Study in Saint Lucia. Within just one year of its January 2025 launch, the project enrolled 154 men across all designated participant categories: those diagnosed with prostate cancer, first-degree relatives of affected individuals, and control subjects without cancer history.
This accomplishment represents a pivotal advancement in addressing the disproportionately high incidence of prostate cancer among Caribbean men, who experience more aggressive disease variants and poorer health outcomes compared to global populations. Despite meeting formal recruitment targets, the organization continues to accept eligible participants who have previously expressed interest.
The overwhelming response demonstrates substantial community involvement and increasing public recognition of genetics’ role in shaping long-term health prospects. Participants received complimentary prostate-specific antigen (PSA) screenings, early detection services, and genetic wellness evaluations providing personalized insights into DNA-based disease risks.
Ongoing genetic analysis has already commenced, with preliminary findings being disseminated to participants. Subsequent research phases will concentrate on synthesizing genetic, clinical, and demographic data to enhance population-level comprehension of prostate cancer determinants throughout the Caribbean region.
Buoyed by this success, CariGenetics plans to extend the study to Grenada and Trinidad and Tobago, forming part of a broader regional initiative. Future investigations will examine how results can refine risk prediction methodologies—including polygenic risk scores—and develop screening protocols specifically tailored for Caribbean demographics. Ultimately, researchers aim to integrate genomic advancements into regional healthcare infrastructure.
Davy Frederick of GenTech Analytica, a collaborating partner, expressed astonishment at the exceptional participation rate, noting that engagement levels surpassed all anticipations despite genomics research being relatively novel in Saint Lucia. CariGenetics additionally recognized contributions from Laboratory Services & Consultations and healthcare professionals, reaffirming its dedication to ethical research practices and ensuring Caribbean communities benefit directly from genomic science innovations.